Vaccsys Raises $18 Million

Vaccsys Inc., a Seattle-based vaccine developer, has called down $9 million of an $18 million Series A round, according to a regulatory filing. Backers include Alta Partners, The Column Group and Versant Ventures. The company's technologies “regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.” www.vaccsys.com